Because of their antimicrobial properties, the use of silver nanoparticles (AgNPs) is
increasing fast in industry, food, and medicine. In the food industry, nanoparticles are used …

There is considerable evidence that the antioxidant activity of high density lipoprotein (HDL)
is largely due to the paraoxonase-1 (PON1) located on it. Experiments with transgenic PON1 …

Epidemiologic studies detected an inverse relationship between HDL (high-density
lipoprotein) cholesterol (HDL-C) levels and atherosclerotic cardiovascular disease …

Paraoxonase 1 (PON1) is a serum enzyme closely associated with high density lipoprotein
(HDL). PON1 hydrolyzes several organophosphorus compounds used as insecticides, as …

The inverse correlation between serum levels of high density lipoprotein (HDL) cholesterol
and the risk of coronary heart disease, the protection of susceptible animals from …

Human serum paraoxonase (PON1) hydrolyzes oxidized lipids in low density lipoprotein
(LDL) and could therefore retard the development of atherosclerosis. In keeping with this …

Inhibition of lipid peroxidation contributes to the attenuation of macrophage cholesterol
accumulation, foam-cell formation and atherosclerosis. Evidence suggests that nutritional …

Research into the paraoxonase (PON) gene family has flourished over the past few years. In
the 1970s and 1980s, only PON1 was known, and the investigations were conducted …

Epidemiologic, genetic, and biochemical studies support an antiatherogenic role for
paraoxonase (PON) 1. While the precise mechanism by which PON1 protects against the …

The protective effect of HDL against the development of atherosclerosis appears to be
multifaceted involving a number of mechanisms. One of the major mechanisms is, however …